Asset Management One
UTHR icon

Asset Management One’s United Therapeutics UTHR Stock Holding History

Asset Management One’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Sell
22,742
-980
-4% -$552K 0.03% 420
2026
Q1 		$14.1M Buy
23,722
+455
+2% +$227K 0.04% 362
2025
Q4 		$11.7M Sell
23,267
-1,243
-5% -$579K 0.03% 421
2025
Q3 		$10.3M Sell
24,510
-541
-2% -$182K 0.03% 449
2025
Q2 		$7.2M Sell
25,051
-822
-3% -$246K 0.02% 532
2025
Q1 		$7.98M Sell
25,873
-241
-0.9% -$82.6K 0.03% 480
2024
Q4 		$9.4M Sell
26,114
-608
-2% -$223K 0.03% 444
2024
Q3 		$9.58M Sell
26,722
-19
-0.1% -$6.42K 0.03% 439
2024
Q2 		$8.52M Buy
26,741
+6,663
+33% +$1.76M 0.03% 446
2024
Q1 		$4.61M Sell
20,078
-3,411
-15% -$770K 0.02% 606
2023
Q4 		$5.15M Buy
23,489
+521
+2% +$120K 0.02% 587
2023
Q3 		$5.19M Buy
22,968
+633
+3% +$146K 0.02% 563
2023
Q2 		$4.93M Buy
22,335
+3,397
+18% +$752K 0.02% 589
2023
Q1 		$4.24M Buy
+18,938
New +$4.67M 0.02% 623
2019
Q2 		– Sell
-23,533
Closed -$2.76M – 1099
2019
Q1 		$2.76M Sell
23,533
-52,422
-69% -$6.11M 0.01% 733
2018
Q4 		$8.23M Sell
75,955
-1,645
-2% -$191K 0.02% 624
2018
Q3 		$9.9M Sell
77,600
-544
-0.7% -$67.3K 0.02% 633
2018
Q2 		$8.82M Buy
78,144
+1,635
+2% +$180K 0.02% 661
2018
Q1 		$8.6M Buy
76,509
+878
+1% +$112K 0.02% 659
2017
Q4 		$11.2M Sell
75,631
-7,057
-9% -$897K 0.02% 630
2017
Q3 		$9.72M Buy
82,688
+15,805
+24% +$2.02M 0.02% 635
2017
Q2 		$8.68M Sell
66,883
-8
-0% -$998 0.02% 631
2017
Q1 		$9.06M Sell
66,891
-5,810
-8% -$880K 0.02% 604
2016
Q4 		$10.4M Sell
72,701
-23,694
-25% -$3.03M 0.03% 594
2016
Q3 		$11.4M Sell
96,395
-611
-0.6% -$73.4K 0.17% 140
2016
Q2 		$10.3M Buy
97,006
+21,848
+29% +$2.44M 0.15% 152
2016
Q1 		$8.37M Buy
75,158
+700
+0.9% +$88.6K 0.12% 184
2015
Q4 		$11.7M Sell
74,458
-200
-0.3% -$29.1K 0.17% 139
2015
Q3 		$9.82M Buy
74,658
+4,106
+6% +$659K 0.15% 161
2015
Q2 		$12.3M Sell
70,552
-14,913
-17% -$2.68M 0.17% 140
2015
Q1 		$14.7M Hold
85,465
– – 0.18% 126
2014
Q4 		$11.1M Sell
85,465
-12,291
-13% -$1.58M 0.14% 171
2014
Q3 		$12.6M Sell
97,756
-7,202
-7% -$742K 0.17% 135
2014
Q2 		$9.29M Hold
104,958
– – 0.14% 173
2014
Q1 		$9.87M Hold
104,958
– – 0.16% 155
2013
Q4 		$11.9M Hold
104,958
– – 0.18% 127
2013
Q3 		$8.28M Hold
104,958
– – 0.12% 185
2013
Q2 		$6.91M Buy
+104,958
New +$6.76M 0.11% 195

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Asset Management One's UTHR Position: Q2 2026 in Review

Asset Management One reduced its United Therapeutics (UTHR) stake by 4.1% in Q2 2026, selling an estimated $552K and leaving 22,742 shares worth $12.3M. The position accounts for 0.03% of the portfolio, ranked #420.

Asset Management One first reported a position in UTHR in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.7M in Q1 2015. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Asset Management One held 22,742 shares of United Therapeutics worth $12.3M as of Q2 2026.
  • Asset Management One sold 980 United Therapeutics shares in Q2 2026, an estimated $552K.
  • United Therapeutics made up 0.03% of Asset Management One's portfolio in Q2 2026, its #420 holding.
  • Asset Management One first reported a position in United Therapeutics in Q2 2013 and has held it in 38 quarters since.
  • Asset Management One's United Therapeutics position peaked at $14.7M in Q1 2015.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.